{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:19:03Z","timestamp":1773382743393,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10549-020-06011-8","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T16:06:28Z","timestamp":1604937988000},"page":"527-534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach"],"prefix":"10.1007","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5246-7388","authenticated-orcid":false,"given":"Andrea P.","family":"Damin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maira","family":"Zancan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia P.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge V.","family":"Biazus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"6011_CR1","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1200\/JCO.19.02576","volume":"38","author":"M Morrow","year":"2020","unstructured":"Morrow M, Khan AJ (2020) Locoregional management after neoadjuvant chemotherapy. J Clin Oncol 38:2281\u20132289","journal-title":"J Clin Oncol"},{"key":"6011_CR2","unstructured":"Surgical axillary staging. National Comprehensive Cancer Network (NCCN). Version 6.2020\u2014September 8, 2020. BINV-D"},{"key":"6011_CR3","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/annonc\/mdy192","volume":"29","author":"F Cardoso","year":"2018","unstructured":"Cardoso F, Senkus E, Costa A et al (2018) 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)\u2020. Ann Oncol 29:1634\u20131657","journal-title":"Ann Oncol"},{"key":"6011_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000499931","volume":"14","author":"M Balic","year":"2019","unstructured":"Balic M, Thomssen C, W\u00fcrstlein R, Gnant M, Harbeck N (2019) St. Gallen\/Vienna 2019: a brief summary of the consensus discussion on the optimal primary breast cancer treatment. Breast Care 14:103\u2013110","journal-title":"Breast Care"},{"key":"6011_CR5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310:1455\u20131461","journal-title":"JAMA"},{"key":"6011_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 14:609\u2013618","journal-title":"Lancet Oncol"},{"key":"6011_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M et al (2015) Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol 33:258\u2013264","journal-title":"J Clin Oncol"},{"key":"6011_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","volume":"173","author":"JM Classe","year":"2019","unstructured":"Classe JM, Loaec C, Gimbergues P et al (2019) Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat 173:343\u2013352","journal-title":"Breast Cancer Res Treat"},{"key":"6011_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1200\/JGO.19.00351","volume":"6","author":"FP Cavalcante","year":"2020","unstructured":"Cavalcante FP, Millen EC, Zerwes FP, Novita GG (2020) Role of axillary surgery after neoadjuvant chemotherapy. JCO Glob Oncol 6:238\u2013241","journal-title":"JCO Glob Oncol"},{"issue":"3","key":"6011_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-020-05589-3","volume":"180","author":"JM Simons","year":"2020","unstructured":"Simons JM, Koppert LB, Luiten EJT et al (2020) De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study. Breast Cancer Res Treat 180(3):725\u2013733","journal-title":"Breast Cancer Res Treat"},{"key":"6011_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejso.2015.11.019","volume":"42","author":"V Galimberti","year":"2016","unstructured":"Galimberti V, Fontana SKR, Maisonneuve P et al (2016) Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment. Eur J Surg Oncol 42:361\u2013368","journal-title":"Eur J Surg Oncol"},{"key":"6011_CR12","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/bjs.10986","volume":"105","author":"SR Tee","year":"2018","unstructured":"Tee SR, Devane LA, Evoy D et al (2018) Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven nodepositive breast cancer. Br J Surg 105:1541\u20131552","journal-title":"Br J Surg"},{"issue":"1","key":"6011_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10549-010-1228-x","volume":"125","author":"G von Minckwitz","year":"2011","unstructured":"von Minckwitz G, Untch M, Nuesch E et al (2011) Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials. Breast Cancer Res Treat 125(1):145\u2013156","journal-title":"Breast Cancer Res Treat"},{"key":"6011_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10549-017-4155-2","volume":"163","author":"B Goorts","year":"2017","unstructured":"Goorts B, van Nijnatten TJ, de Munck L et al (2017) Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat 163:83\u201391","journal-title":"Breast Cancer Res Treat"},{"key":"6011_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.adro.2019.09.006","volume":"5","author":"DC Ling","year":"2020","unstructured":"Ling DC, Iarrobino NA, Champ CE et al (2020) Regional recurrence rates with or without complete axillary dissection for breast cancer patients with node-positive disease on sentinel lymph node biopsy after neoadjuvant chemotherapy. Adv Radiat Oncol 5:163\u2013170","journal-title":"Adv Radiat Oncol"},{"key":"6011_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/01.sla.0000245472.47748.ec","volume":"245","author":"I Langer","year":"2007","unstructured":"Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (sln) alone versus sln and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245:452\u2013461","journal-title":"Ann Surg"},{"key":"6011_CR17","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1200\/JCO.2012.45.0940","volume":"31","author":"G von Minckwitz","year":"2013","unstructured":"von Minckwitz G, Blohmer JU, Costa SD et al (2013) Response-guided neoadjuvant chemotherapy for breast cancer. J Clin Oncol 31:3623\u20133630","journal-title":"J Clin Oncol"},{"key":"6011_CR18","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","volume":"26","author":"LM Spring","year":"2020","unstructured":"Spring LM, Fell G, Arfe A et al (2020) Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis. Clin Cancer Res 26:2838\u20132848","journal-title":"Clin Cancer Res"},{"key":"6011_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/SLA.0000000000002373","volume":"266","author":"JC Boughey","year":"2017","unstructured":"Boughey JC, Ballman KV, McCall LM et al (2017) Tumor biology and response to chemotherapy impact breast cancer-specific survival in node-positive breast cancer patients treated with neoadjuvant chemotherapy: long-term follow-up from ACOSOG Z1071 (Alliance). Ann Surg 266:667\u2013676","journal-title":"Ann Surg"},{"key":"6011_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.breast.2017.05.015","volume":"35","author":"A Peppe","year":"2017","unstructured":"Peppe A, Wilson R, Pope R et al (2017) The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT). Breast 35:104\u2013108","journal-title":"Breast"},{"key":"6011_CR21","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ejso.2019.01.219","volume":"45","author":"R Di Micco","year":"2019","unstructured":"Di Micco R, Zuber V, Fiacco E et al (2019) Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: time trend, imaging staging power and nodal downstaging according to molecular subtype. Eur J Surg Oncol 45:969\u2013975","journal-title":"Eur J Surg Oncol"},{"key":"6011_CR22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ejso.2018.10.001","volume":"45","author":"R Helfgott","year":"2019","unstructured":"Helfgott R, Mittlb\u0151ck M, Miesbauer M et al (2019) The influence of breast cancer subtypes on axillary ultrasound accuracy: a retrospective single center analysis of 583 women. Eur J Surg Oncol 45:538\u2013543","journal-title":"Eur J Surg Oncol"},{"key":"6011_CR23","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1245\/s10434-013-3118-z","volume":"20","author":"TJ Hieken","year":"2013","unstructured":"Hieken TJ, Boughey JC, Jones KN et al (2013) Imaging response and residual metastatic axillary lymph node diseases after neoadjuvant chemotherapy for primary breast cancer. Ann Surg Oncol 20:3199\u20133204","journal-title":"Ann Surg Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-020-06011-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T17:22:13Z","timestamp":1616606533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-020-06011-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["6011"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-06011-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"10 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants followed the ethical standards of the institutional and national research committee and the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All information was obtained from the electronic hospital records. Additional informed consent was also obtained from the hospital, where information and databases were collected. The researchers are committed to preserving the privacy of patients, and they also agree that the information was used exclusively to study. Research involving human participants for the retrospective cohort study, individual formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}